Avid Bioservices Inc (CDMO)

[geocappy1]

Is there any chance the delay could be due to the FDA saying we need more support to allow the 2nd line lung to move to phase III (political cover) and when the 1st line lung and pancreatic MOS data comes in we will use it to prop up the flawed 2nd line lung data when we allow it to move forward.

IMO whatever the situation is must involve something that they can't make public regardless if it is good or bad. If good, it could be as simple as above. If bad, could it be they want to keep the pps above $1 Gil after Monday. I hope this is not the case for many reasons.

For me, it is hard to believe Garnick can't get the FDA to go along with the patients in the 2nd line lung must be living because Bavi is at least effective and deserves to move forward. Maybe the FDA said lets wait until we get more MOS data from the other trials.

Who knows?